Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination

Journal of Virology

Volumn 73, Issue 11, 1999, Pages 9468-9477

  Yang, Jusan ^a   Zhou, Weihong ^a   Zhang, Yulong ^a   Zidon, Terese ^a   Ritchie, Terry ^a   Engelhardt, John F ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMPICILLIN; CIRCULAR DNA; GREEN FLUORESCENT PROTEIN; RECOMBINANT PROTEIN; VIRUS DNA; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA RECOMBINATION; DNA REPLICATION ORIGIN; GENE AMPLIFICATION; GENE TARGETING; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SKELETAL MUSCLE; TRANSGENE; VIRUS GENOME;

EID: 0032862285     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.11.9468-9477.1999     Document Type: Article

References (30)

1. Afione, S. A., C. K. Conrad, W. G. Kearns, S. Chunduni, R. Adams, T. C. Reynolds, W. B. Guggino, G. R. Cutting, B. J. Carter, and T. R. Flotte. 1996. In vivo model of adeno-associated virus vector persistence and rescue. J. Virol. 70:3235-3241.
2. Ali, R. R., M. B. Reichel, A. J. Thrasher, R. J. Lerinsky, C Kinnon, N. Kanuga, D. M. Hunt, and S. S. Bhattacharya. 1996. Gene transfer into the mouse retina mediated by an adeno-associated viral vector. Hum. Mol. Genet. 5:591-594.
3. Berns, K. I. 1990. Parvovirus replication. Microbiol. Rev. 54:316-329.
4. Duan, D., K. J. Fisher, J. F. Burda, and J. F. Engelhardt 1997. Structural and functional heterogeneity of integrated recombinant AAV genomes. Virus Res. 48:41-56.
5. Duan, D., P. Sharma, J. Yang, Y. Yue, L. Dudus, Y. Zhang, K. J. Fisher, and J. F. Engelhardt. 1998. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle. J. Virol. 72:8568-8577.
6. Duan, D., Y. Yue, Z. Yan, P. B. McCray, and J. F. Engelhardt. 1999. Polarity influences the efficiency of recombinant adeno-associated virus infection in differentiated airway epithelia. Hum. Gene Ther. 9:2761-2776.
7. Engelhardt, J. F., H. Schlossberg, J. R. Yankaskas, and L. Dudus. 1995. Progenitor cells of the adult human airway involved in submucosal gland development. Development 121:2031-2046.
8. Fisher, K. J., K. Jooss, J. Alston, Y. Yang, S. E. Haecker, K. High, R. Pathak, S. E. Raper, and J. M. Wilson. 1997. Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3:306-312.
9. Fisher-Adams, G., K. K. Wong, Jr., G. Podsakoff, S. J. Forman, and S. Chatterjee. 1996. Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction. Blood 88:492-504.
10. Flotte, T. R., S. A. Afione, and P. L. Zeitlin. 1994. Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am. J. Respif. Cell. Mol. Biol. 11:517-521.
11. Halbert, C. L., T. A. Standaert, M. L. Aitken, I. E. Alexander, D. W. Russell, and A. D. Miller. 1997. Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J. Virol. 71:5932-41.
12. Herzog, R. W., J. N. Hagstrom, S. H. Kung, S. J. Tai, J. M. Wilson, K. J. Fisher, and K. A. High, 1997. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA 94:5804-5809.
13. Kaplitt, M. G., P. Leone, R. J. Samulski, X. Xiao, D. W. Pfaff, K. L. O'Malley, and M. J. During. 1994. Long-term gene expression and phenorypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:148-154.
14. Kearns, W. G., S. A. Afione, S. B. Fulmer, M. C. Pang, D. Erikson, M. Egan, M. J. Landrum, T. R. Flotte, and G. R. Cutting. 1996. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther. 3:748-755.
15. Kessler, P. D., G. M. Podsakoff, X. Chen, S. A. McQuiston, P. C. Colosi, L. A. Matelis, G. J. Kurtzman, and B. J. Byrne. 1996. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93:14082-7.
16. Kotin, R. M., R. M. Linden, and K. I. Berns. 1992. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11:5071-5078.
17. McLaughlin, S. K., P. Collis, P. L. Hermonat, and N. Muzyczka. 1988. Adeno-associated virus general transduction vectors: analysis of proviral structures. J. Virol. 62:1963-1973.
18. Miao, C. H., R. O. Snyder, D. B. Schowalter, G. A. Patijn, B. Donahue, B. Whither, and M. A. Kay. 1998. The kinetics of rAAV integration in the liver. Nat Genet. 19:13-15. (Letter.)
19. Ponnazhagan, S., D. Erikson, W. G. Kearns, S. Z. Zhou, P. Nahreini, X. S. Wang, and A. Srivastava. 1997. Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Hum. Gene Ther. 8:275-284.
20. Qing, K., B. Khuntirat, C. Mah, D. M. Kube, X. S. Wang, S. Ponnazhagan, S. Zhou, V. J. Dwarki, M. C. Yoder, and A. Srivastava. 1998. Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo. J. Virol. 72:1593-1599.
21. Qing, K., C. Mah, J. Hansen, S. Zhou, V. Dwarki, and A. Srivastava. 1999. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 5:71-77.
22. Qing, K., X. S. Wang, D. M. Kube, S. Ponnazhagan, A. Bajpai, and A. Srivastava. 1997. Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc. Natl. Acad. Sci. USA 94:10879-10884.
23. Samulski, R. J., L. S. Chang, and T. Shenk. 1989. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63:3822-3828.
24. Samulski, R. J., L. S. Chang, and T. Shenk. 1987. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 61:3095-3101.
25. Summerford, C., J. S. Bartlett, and R. J. Samulski. 1999. AlphaVbeta5 integrin: a co-receptor for adeno-assodated virus type 2 infection. Nat. Med. 5:78-82.
26. Summerford, C., and R. J. Samulski. 1998. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72:1438-1445.
27. Vincent-Lacaze, N., R. O. Snyder, R Gluzman, D. Bohl, C. Lagarde, and O. Danos. 1999. Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle. J. Virol. 73:1949-1955.
28. Westfall, T. D., C. Kennedy, and P. Sneddon. 1997. The ecto-ATPase inhibitor ARL 67156 enhances parasympathetic neurotransmission in the guinea-pig urinary bladder. Eur. J. Pharmacol. 329:169-173.
29. Wu, P., M. I. Phillips, J. Bui, and E. F. Terwilliger. 1998. Adeno-associated virus vector-mediated transgene integration into neurons and other nondi-viding cell targets. J. Virol. 72:5919-5926.
30. Xiao, X., J. Li, and R. J. Samulski. 1996. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:8098-8108.